December 8, 2025BloodOpen Access

Clinical analysis of central nervous system leukemia in patients with Acute Myeloid Leukemia

View Full Paper

Ask AI

Bookmark

Authors

JWJunqing WuZhejiang Chinese Medical University WZWeiyan ZhengFirst Affiliated Hospital Zhejiang University

Discussion

Member takes

Implication

Observational analysis revealed delayed CNS leukemia onset in acute myeloid leukemia with prophylactic IT chemotherapy, suggesting improved outcomes in specific subtypes.

Key Points

Prophylactic intrathecal chemotherapy significantly delayed CNS leukemia onset in acute myeloid leukemia patients.
Among 54 patients, white blood cell counts at diagnosis averaged 65.1 × 10⁹/L, with a notable impact on CNSL development.
Next-generation sequencing identified key gene mutations, including FLT3 and CEBPA, influencing treatment responses and outcomes.
Findings highlight the critical need for further prospective studies to validate the efficacy of prophylactic strategies in reducing CNSL occurrences.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da05 https://doi.org/10.1182/blood-2025-5184

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis revealed delayed CNS leukemia onset in acute myeloid leukemia with prophylactic IT chemotherapy, suggesting improved outcomes in specific subtypes.

Clinical analysis of central nervous system leukemia in patients with Acute Myeloid Leukemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Clinical analysis of central nervous system leukemia in patients with Acute Myeloid Leukemia

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider